Preclinical Efficacy of a Novel CD8-Targeted Fusosome for In Vivo CAR T Cell Therapy

Vandana Chaturvedi(Sana Biotechnology (United States)), Terry J. Fry(University of Colorado Anschutz Medical Campus), Garrett Zipp(Sana Biotechnology (United States)), Ouwen Liang(Sana Biotechnology (United States)), Kutlu G. Elpek(Sana Biotechnology (United States)), Allison O’Rourke(Sana Biotechnology (United States)), Aaron Lampano(Fred Hutch Cancer Center), Brian Granger(Sana Biotechnology (United States)), Jesse Green(Sana Biotechnology (United States)), Neal Van Hoeven(Sana Biotechnology (United States))
Blood
November 2, 2023
Cited by 3


Related Papers